Cargando…

Graves’ Disease Induced Severe Hypercalcemia

Introduction: Hyperthyroidism is a well-known non-parathyroid hormone-mediated cause of hypercalcemia. Hypercalcemia associated with thyrotoxicosis is usually asymptomatic. Increased osteoclastogenesis is one of the mechanisms underlying this etiology. Hyperthyroidism is associated with mild to mode...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lugo Lopez, Zahira Marie, Penna, Laurianne El Musa, Ortiz, Arnaldo Nieves, Rivera, Ivan Augusto, Diez, Andrea del Toro, Bossolo, Alex N Gonzalez, Garcia, Michelle Marie Mangual
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090085/ http://dx.doi.org/10.1210/jendso/bvab048.1903

Ejemplares similares

FRI572 Teprotumumab In Unexplored Presentation Of Thyroid Eye Disease
por: Torres Torres, Marina T, et al.
Publicado: (2023)

SAT-577 Managing Patients with Contrasting Thyroid Dysfunction: Is Definitive Treatment Necessary?
por: Zayas, Francisco, et al.
Publicado: (2019)

SUN-627 Unexpected Presentation of a Primary Thyroid T-Cell Lymphoma
por: Vergne-Santiago, Norma, et al.
Publicado: (2019)

MON-243 Atypical Presentation of Isolated Adrenocorticotropic Hormone Deficiency and Sheehan’s Syndrome
por: Lugo López, Zahira Marie, et al.
Publicado: (2020)

SAT-617 Lingual Thyroid Gland: It's Time for Awareness
por: Cruz Dardiz, Nicolas, et al.
Publicado: (2019)

FRI570 Repatha Induced Thyroid Storm
por: Sepulveda-Garcia, Luis Ruben, et al.
Publicado: (2023)

Incidental Diffuse Sclerosing Variant Papillary Thyroid Cancer in Grave’s Disease
por: Canales, Nicolle, et al.
Publicado: (2021)

A Case of Diffuse Sclerosing Variant of Papillary Thyroid Cancer: An Aggressive Variant Presenting With Recurrent Locoregional Nodal Disease
por: Cruz, Yaniris García, et al.
Publicado: (2021)

SAT-679 Autoimmune Hypoglycemia: A Treatment Challenge
por: Santana, Nadyeschka Angelique Rivera, et al.
Publicado: (2020)

An Unusual Etiology of Graves’ Disease: Alemtuzumab
por: Santiago Carrion, Ada Marie, et al.
Publicado: (2021)

SAT-412 Genetic Susceptibility to Graves’ Disease Conferred by HLA-DQβ1 Position 57
por: Badenhoop, Klaus, et al.
Publicado: (2020)

A Grave Turn on Hashimoto’s Thyroiditis - A Case Series on Four Patients With Autoimmune Hypothyroidism that Converted to Grave’s Disease
por: Lee, Michelle N, et al.
Publicado: (2021)

MON-152 Less Is More: Human Regular U-500 Insulin
por: Lugo Lopez, Zahira, et al.
Publicado: (2019)

A Grave Initial Presentation of Graves’ Disease in a Patient With Moyamoya
por: Clutter, Courtney, et al.
Publicado: (2021)

Graves’ Disease, a Late Complication of Chronic Graft vs Host Disease
por: Kreit, Helen, et al.
Publicado: (2021)

Graves Disease in Infancy
por: Beliard, Kara A, et al.
Publicado: (2021)

The Thionamide Paradox: Thyrotoxicosis With Neutropenia as Initial Presentation of Grave’s Disease
por: Celis, Valentina, et al.
Publicado: (2021)

PSAT358 Graves’ Disease Complicated by Post-Operative Graves’ Ophthalmopathy and Pretibial Myxedema
por: Bowens, Brendan, et al.
Publicado: (2022)

SUN-502 Graves’Disease and Autoimmune Hepatitis: Management Challenges
por: Soares, Maria Marta Sarquis, et al.
Publicado: (2020)

Leukocytosis and PTHrP-Mediated Hypercalcemia: Ominous Signs in an Indolent Thyroid Nodule
por: Gerwer, Johanna Elizabeth, et al.
Publicado: (2021)

LBODP069 Parathyroid Crisis And Recalcitrant Hypercalcemia From Double Parathyroid Adenomas
por: Parihar, Aisha, et al.
Publicado: (2022)

The Grave Hematologic and Hepatic Effects of Hyperthyroidism
por: Ahmad, Sara Miriam, et al.
Publicado: (2021)

Presentation and Outcome of Severe Graves’ Disease
por: Babu, Priya Mohan, et al.
Publicado: (2021)

SUN-621 Lessons from beyond the Graves'
por: Chai, Thora, et al.
Publicado: (2019)

SUN-567 Moyamoya and Autoimmune Graves' Disease
por: Elagi, Daniyah, et al.
Publicado: (2019)

SAT-476 Alemtuzumab Induced Graves Disease
por: Caputi, Rafael C, et al.
Publicado: (2020)

SAT489 Grave’s Disease Secondary To Alemtuzumabuse
por: Gong, Michael Shifeng, et al.
Publicado: (2023)

MON-590 Outcomes Following Radioactive Iodine Therapy (RAI) in Hyperthyroid Patients with Grave’s Disease and Toxic Nodular Disease
por: Aljenaee, Khaled, et al.
Publicado: (2019)

PSAT324 Altered Mental Status, Hypercalcemia, and Atrial Fibrillation Induced by Post-Parathyroidectomy Thyroiditis
por: Boeder, Schafer, et al.
Publicado: (2022)

ODP502 Nodular Pretibial Myxedema without Graves’ Orbitopathy: A Case Report
por: Veeramachaneni, Ravali, et al.
Publicado: (2022)

PSAT345 Neonatal Graves (NG) Affecting 3 Newborns of a Mother Treated with Radioactive Iodine (RAI) for Graves’ Disease (GD)
por: Ali, Dalal S, et al.
Publicado: (2022)

Early Biochemical Response to Antithyroid Drugs in Graves’ Disease: The Role of Initial Dosing
por: El Kawkgi, Omar M, et al.
Publicado: (2021)

SAT-603 Graves' Disease and an Anterior Mediastinal Mass
por: Robbins, D'lorah, et al.
Publicado: (2019)

OR10-2 A Modifying Autoantigen in Graves' Disease
por: Latif, Rauf, et al.
Publicado: (2019)

SAT-592 Amiodarone-Induced Cure Of Graves' Disease
por: Sharma, Eliza, et al.
Publicado: (2019)

SAT-605 Immune Thrombocytopenic Purpura in Graves' disease
por: Sajja, Puspalatha, et al.
Publicado: (2019)

SUN-578 Severe Hyperbilirubinemia Due to Graves' Thyrotoxicosis
por: Thampi, Rahul, et al.
Publicado: (2019)

SAT-582 Autoimmune Hepatitis Presenting with Graves Disease
por: Coy, Andres, et al.
Publicado: (2019)

ODP533 Graves’ Ophthalmopathy in the Setting of Primary Hypothyroidism
por: Alajmi, Sarah, et al.
Publicado: (2022)

THU668 Euthyroid Graves’ Ophthalmopathy: Case Series
por: Saleh Alfadl, Sultan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8qibt90arsfuaqld4fvqak27a8